Navigation Links
Animal Study Explores Potential Gene Therapy for Depression
Date:10/20/2010

WEDNESDAY, Oct. 20 (HealthDay News) -- A combination of animal and human research is pointing the way towards a novel gene therapy that could ultimately help in the treatment of major depression, researchers say.

The approach is designed to boost levels of a brain protein known as p11. The study authors cite p11 as a key player in the promotion of feelings of reward, pleasure and satisfaction with positive life experiences.

"Current therapies for depression treat symptoms but not underlying causes, and while that works for many patients, those with advanced depression or depression that does not respond to medication could hopefully benefit from our new approach," study senior investigator Dr. Michael Kaplitt, an associate professor and vice chairman for research of neurological surgery at Weill Cornell Medical College, said in a news release from New York-Presbyterian Hospital/Weill Cornell Medical Center.

Kaplitt, who is also a neurosurgeon at New York-Presbyterian Hospital/Weill Cornell, and his colleagues published their findings in the Oct. 20 issue of Science Translational Medicine.

P11's central role in depression was uncovered in 2006 by Nobel Prize winner Dr. Paul Greengard of Rockefeller University. At that time, p11 was identified as a key player in facilitating the binding of the neurotransmitter serotonin -- long cited as a mood, appetite and sleep regulator -- to nerve cells.

"In the absence of p11, a neuron can produce all the serotonin receptors it needs, but they will not be transported to the cell surface and therefore won't stick out and latch on to the neurotransmitter," explained Kaplitt in the news release.

Following discussions with Greengard, Kaplitt further studied p11's role in mice by disabling the protein's ability to function properly in a specific part of the brain called the nucleus accumbens, which is known to be involved in both addiction and depression.

Without p11, the mice displayed depressive behaviors. The investigators then used a technique they had tested in Parkinson's disease patients, in which they engineer a non-functioning virus, pack it with a desired genetic "payload" (in this case, the p11 gene), and then direct the virus to deposit its contents into specifically targeted brain cells.

After the gene was delivered to the animals' p11-inhibited nucleus accumbens regions, the mice stopped displaying depressive behaviors, the researchers reported.

What's more, autopsies conducted on human patients who had been diagnosed with severe depression further revealed that the same region in their brains had significantly lower amounts of the p11 gene than typically found in patients with no signs of depression, the study noted.

"Together, these studies provide strong evidence that maintaining adequate levels of this particular protein, p11, in this pleasure-reward area of the brain may be central to preventing or treating depression," Kaplitt concluded.

However, "patients should not get their hopes up that this is going to turn around the treatment of depression anytime soon," according to Dr. Bernard Carroll, scientific director of the Pacific Behavioral Research Foundation in Carmel, Calif., and a former chairman of the U.S. Food and Drug Administration's advisory committee for psychotropic drugs.

"The laboratory findings are interesting, but the translational step to anything that would benefit a patient is very removed at this point," he noted. "Although the basic neurobiology that is being studied here is well known, depression is a human disorder and animal models do not faithfully reproduce the full syndrome. So while I'm not knocking the science, what I'm knocking is the rush to speculate about how far this will take us."

More information

For more on depression and treatment, visit the U.S. National Institute of Mental Health.

-- Alan Mozes

SOURCES: New York-Presbyterian Hospital/Weill Cornell Medical Center, news release, Oct. 20, 2010; Bernard Carroll, M.D., scientific director, Pacific Behavioral Research Foundation, Carmel, Calif.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. With magnetic nanoparticles, scientists remotely control neurons and animal behavior
2. Hallmark Alzheimers disease changes found in retinas of humans and imaged in live animals
3. Exercise May Combat Alcohol Cravings, Animal Study Suggests
4. Maryland In Home Dog Training Service has a Mission to Keep "Dogs with Behavior Problems" Out of the Animal Shelters
5. Females May Be Naturally More Prone to Stress: Animal Study
6. United Soybean Board New Site Features Farmers', Ranchers' Animal Care
7. Better animal-free test for chemicals that can cause contact dermatitis
8. Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved
9. McGill-UBC project creates mouse grimace scale to help identify pain in humans and animals
10. FDA Updates Import Alert 71-04 for Salmonella Contaminated Animal Feeds: Many Non-U.S. Firms Affected According to FDAImports.com, LLC
11. The effect of dietary supplements, acids and animal protein on gastrointestinal disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Animal Study Explores Potential Gene Therapy for Depression
(Date:6/27/2016)... ... June 27, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... workers from extreme heat at their worksites. Employers with workers exposed to ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: